News & Updates

Show Multimedia Only

Glaucoma more prevalent in women with COPD

14 Oct 2022

The risk of open-angle glaucoma (OAG) appears to be aggravated among women with chronic obstructive pulmonary disease (COPD), reports a recent study.

14 Oct 2022

5-fluorouracil plus heparin no better than placebo in preventing proliferative vitreoretinopathy

03 Oct 2022

Adjuvant therapy with 5-fluorouracil and low-molecular weight heparin (LMWH) is not superior to placebo in the prevention of proliferative vitreoretinopathy (PVR) in eyes with rhegmatogenous retinal detachment (RRD), reports a study.

03 Oct 2022

Younger patients with small lesions unlikely to see nAMD recurrence

02 Oct 2022

In neovascular age-related macular degeneration (nAMD), the absence of exudative recurrence after three loading doses of antivascular endothelial growth factor (VEGF) is associated with younger age, smaller lesion size, and having no fibrovascular pigment epithelial detachment (PED), a recent study has found.

02 Oct 2022

Brolucizumab for neovascular age-related macular degeneration holds up in real world

30 Sep 2022

The use of brolucizumab for the treatment of patients with neovascular age-related macular degeneration (nAMD) in the real-world setting appears to be effective and safe, consistent with data from pivotal trials, as reported in a study.

30 Sep 2022

SGLT2 inhibitors potentially protective against dry eye disease

29 Sep 2022 by

Type 2 diabetes (T2D) patients on sodium-glucose cotransporter 2 (SGLT2) inhibitors appear to be at lower risk of dry eye disease (DED) compared with their counterparts who are receiving glucagonlike peptide-1 receptor agonists (GLP-1 RAs), as shown in a study.

29 Sep 2022

Low-, very low-dose bevacizumab for retinopathy of prematurity yield good outcomes

29 Sep 2022

Use of low- and very low-dose intravitreal bevacizumab (IVB) as initial treatment for type 1 retinopathy of prematurity (ROP) leads to satisfactory retinal structural outcomes, reports a study, noting that many eyes have received additional treatment.

29 Sep 2022

Vision impairment tied to depression, anxiety in children

28 Sep 2022 by

Children with vision impairment are at higher risk of developing symptoms of depression and anxiety, according to a study, noting that surgical treatment of strabismus may improve these symptoms.

28 Sep 2022

OFA unreliable at differentiating papilledema from pseudopapilledema in kids

12 Sep 2022

A recent study showed that oral fluorescein angiography (OFA) cannot definitively distinguish papilledema from pseudopapilledema in children, highlighting the need to interpret OFA findings in conjunction with other clinical findings.

12 Sep 2022

Regular coffee intake ups risk of primary open-angle glaucoma

06 Sep 2022 by

Genetic evidence from a recent study suggests that habitual coffee drinkers have an increased risk of primary open-angle glaucoma (POAG).

06 Sep 2022

Glaucoma risk modestly low in diabetes

04 Sep 2022

Patients with diabetes mellitus are at reduced risk of developing open-angle glaucoma (OAG), although the magnitude of reduction is modest, according to a study.

04 Sep 2022

News & Updates

Showing Ophthalmology articles

Showing

Specialty:

Glaucoma more prevalent in women with COPD

5-fluorouracil plus heparin no better than placebo in preventing proliferative vitreoretinopathy

Younger patients with small lesions unlikely to see nAMD recurrence

Brolucizumab for neovascular age-related macular degeneration holds up in real world

SGLT2 inhibitors potentially protective against dry eye disease

Low-, very low-dose bevacizumab for retinopathy of prematurity yield good outcomes

Vision impairment tied to depression, anxiety in children

OFA unreliable at differentiating papilledema from pseudopapilledema in kids

Regular coffee intake ups risk of primary open-angle glaucoma

Glaucoma risk modestly low in diabetes